Author

Justin Donnelly

Stanford UniversityORCID 0009-0000-1480-7372Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Genetic & Genomic Medicine· 1 Molecular Biology· 1 Neuroscience· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 3 Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Research Focus:cell type annotation· 1 Approach:deep learning· 1 Research Focus:differential expression· 1 Assay:electronic health records· 1 Assay:metabolomics· 1

Frequent Co-Authors

Ethan O. PerlsteiniD· 2 shared Agnieszka Rybak‐WolfiD· 1 shared Akhilesh PandeyiD· 1 shared Alessandro PrigioneiD· 1 shared Andrea Rossi· 1 shared Andrea ZalianiiD· 1 shared Annette Seibt· 1 shared Annika WittichiD· 1 shared

Activity by Year

2024-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 37 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersGenetic & Genomic Medicine

Ethan O. PerlsteinORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Genetic & Genomic MedicinemedRxivPreprintJun 5, 2026

DHDDS-related juvenile parkinsonism is caused by impaired lipid metabolism, glycosylation, and mitochondrial dysfunction, which can be rescued by NAD⁺ treatment.

Irena Josephina Johanna Muffels, Kristin A. Kantautas, Georgia MacDonald…·Éva Morava

This study identifies mitochondrial dysfunction and metabolic impairments in DHDDS-related juvenile parkinsonism and shows that NMN treatment improves symptoms in patient-derived organoids and clinical cases.

DOI 10.64898/2026.05.28.26354198

humanproteomics

𝕏 PostBluesky

NeurosciencebioRxivPreprintJul 8, 2024

Deep learning-driven neuromorphogenesis screenings identify repurposable drugs for mitochondrial disease

Carmen Menacho, Satoshi Okawa, Iris Álvarez‐Merz…·Alessandro Prigione

The paper identifies repurposable drugs for mitochondrial disease by using deep learning to screen for compounds that improve neuronal commitment and neurogenesis in Leigh syndrome organoids.

9 citations

humanscRNA-seq

𝕏 PostBluesky

Molecular BiologybioRxivPreprintJan 3, 2024

A Genome-Wide CRISPR Screen Identifies Sortilin as the Receptor Responsible for Galectin-1 Lysosomal Trafficking

Justin Donnelly, Roarke A. Kamber, Simon Wisnovsky…·Carolyn Ruth Bertozzi

The paper identifies sortilin as the receptor mediating galectin-1 lysosomal trafficking through a CRISPR screen and demonstrates its use for siRNA delivery.

3 citations

humanexperimental assay

𝕏 PostBluesky